Creta, M.; Celentano, G.; Napolitano, L.; La Rocca, R.; Capece, M.; Califano, G.; Collà Ruvolo, C.; Mangiapia, F.; Morra, S.; Turco, C.;
et al. Inhibition of Androgen Signalling Improves the Outcomes of Therapies for Bladder Cancer: Results from a Systematic Review of Preclinical and Clinical Evidence and Meta-Analysis of Clinical Studies. Diagnostics 2021, 11, 351.
https://doi.org/10.3390/diagnostics11020351
AMA Style
Creta M, Celentano G, Napolitano L, La Rocca R, Capece M, Califano G, Collà Ruvolo C, Mangiapia F, Morra S, Turco C,
et al. Inhibition of Androgen Signalling Improves the Outcomes of Therapies for Bladder Cancer: Results from a Systematic Review of Preclinical and Clinical Evidence and Meta-Analysis of Clinical Studies. Diagnostics. 2021; 11(2):351.
https://doi.org/10.3390/diagnostics11020351
Chicago/Turabian Style
Creta, Massimiliano, Giuseppe Celentano, Luigi Napolitano, Roberto La Rocca, Marco Capece, Gianluigi Califano, Claudia Collà Ruvolo, Francesco Mangiapia, Simone Morra, Carmine Turco,
and et al. 2021. "Inhibition of Androgen Signalling Improves the Outcomes of Therapies for Bladder Cancer: Results from a Systematic Review of Preclinical and Clinical Evidence and Meta-Analysis of Clinical Studies" Diagnostics 11, no. 2: 351.
https://doi.org/10.3390/diagnostics11020351
APA Style
Creta, M., Celentano, G., Napolitano, L., La Rocca, R., Capece, M., Califano, G., Collà Ruvolo, C., Mangiapia, F., Morra, S., Turco, C., Spirito, L., Fusco, F., Imbimbo, C., Mirone, V., & Longo, N.
(2021). Inhibition of Androgen Signalling Improves the Outcomes of Therapies for Bladder Cancer: Results from a Systematic Review of Preclinical and Clinical Evidence and Meta-Analysis of Clinical Studies. Diagnostics, 11(2), 351.
https://doi.org/10.3390/diagnostics11020351
